BECLOMETHASONE DIPROPIONATE AEROSOL IN THE TREATMENT OF CHILDREN WITH SEVERE PERENNIAL RHINITIS
Abstract
Twenty-two children suffering from severe perennial rhinitis were treated with intranasal beclomethasone dipropionate (300 μg/day) and an identical placebo aerosol in a double-blind crossover trial. The results confirmed the value of beclomethasone dipropionate in improving nasal symptoms and signs due to perennial rhinitis, and allergic eye symptoms caused by associated conjunctivitis.